383 related articles for article (PubMed ID: 24717985)
21. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
[TBL] [Abstract][Full Text] [Related]
22. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
[TBL] [Abstract][Full Text] [Related]
23. Molecular basis of facioscapulohumeral muscular dystrophy.
Tupler R; Gabellini D
Cell Mol Life Sci; 2004 Mar; 61(5):557-566. PubMed ID: 15004695
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and genetical features of Japanese early-onset facioscapulohumeral muscular dystrophy].
Yamanaka G; Goto K; Hayashi YK; Miyajima T; Hoshika A; Arahata K
No To Hattatsu; 2002 Jul; 34(4):318-24. PubMed ID: 12134683
[TBL] [Abstract][Full Text] [Related]
25. A severe case of facioscapulohumeral muscular dystrophy (FSHD) with some uncommon clinical features and a short 4q35 fragment.
Dorobek M; Kabzińska D
Eur J Paediatr Neurol; 2004; 8(6):313-6. PubMed ID: 15542386
[TBL] [Abstract][Full Text] [Related]
26. Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD).
Dai Y; Li P; Wang Z; Liang F; Yang F; Fang L; Huang Y; Huang S; Zhou J; Wang D; Cui L; Wang K
J Med Genet; 2020 Feb; 57(2):109-120. PubMed ID: 31506324
[TBL] [Abstract][Full Text] [Related]
27. Equal proportions of affected cells in muscle and blood of a mosaic carrier of facioscapulohumeral muscular dystrophy.
Tonini MM; Lemmers RJ; Pavanello RC; Cerqueira AM; Frants RR; van der Maarel SM; Zatz M
Hum Genet; 2006 Mar; 119(1-2):23-8. PubMed ID: 16341710
[TBL] [Abstract][Full Text] [Related]
28. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.
Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S
Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813
[TBL] [Abstract][Full Text] [Related]
29. [Facioscapulohumeral muscular dystrophy: Report of seven patients].
Cea G; Jiménez D
Rev Med Chil; 2015 Mar; 143(3):304-9. PubMed ID: 26005816
[TBL] [Abstract][Full Text] [Related]
30. FAT1 Gene Alteration in Facioscapulohumeral Muscular Dystrophy Type 1.
Park HJ; Lee W; Kim SH; Lee JH; Shin HY; Kim SM; Park KD; Lee JH; Choi YC
Yonsei Med J; 2018 Mar; 59(2):337-340. PubMed ID: 29436205
[TBL] [Abstract][Full Text] [Related]
31. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
32. Milder phenotype in facioscapulohumeral dystrophy with 7-10 residual D4Z4 repeats.
Statland JM; Donlin-Smith CM; Tapscott SJ; Lemmers RJ; van der Maarel SM; Tawil R
Neurology; 2015 Dec; 85(24):2147-50. PubMed ID: 26561289
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and genetic characteristics of facioscapulohumeral muscular dystrophy Landuzi-Dezherina type 1].
Dadali EL; Sharkova IV; Zernov NV; Rudenskaya GE; Skoblov MY
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):122-128. PubMed ID: 29265097
[TBL] [Abstract][Full Text] [Related]
34. Distinguishing the 4qA and 4qB variants is essential for the diagnosis of facioscapulohumeral muscular dystrophy in the Chinese population.
Wang ZQ; Wang N; van der Maarel S; Murong SX; Wu ZY
Eur J Hum Genet; 2011 Jan; 19(1):64-9. PubMed ID: 20736973
[TBL] [Abstract][Full Text] [Related]
35. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere.
Lemmers RJ; de Kievit P; Sandkuijl L; Padberg GW; van Ommen GJ; Frants RR; van der Maarel SM
Nat Genet; 2002 Oct; 32(2):235-6. PubMed ID: 12355084
[TBL] [Abstract][Full Text] [Related]
36. Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1.
Mul K; Voermans NC; Lemmers RJLF; Jonker MA; van der Vliet PJ; Padberg GW; van Engelen BGM; van der Maarel SM; Horlings CGC
Clin Genet; 2018 Dec; 94(6):521-527. PubMed ID: 30211448
[TBL] [Abstract][Full Text] [Related]
37. Two Cases of Facioscapulohumeral Muscular Dystrophy 2 in Korea.
Lee JH; Park HJ; Seong MW; Park SS; Choi YC
Yonsei Med J; 2021 Jan; 62(1):95-98. PubMed ID: 33381940
[TBL] [Abstract][Full Text] [Related]
38. Severe Glomerular Endothelial Injury Associated with a Short D4Z4 Repeat on Chromosome 4q35.
Hibino S; Takeda A; Nishino I; Iwata N; Nakano M; Tanaka K; Yamakawa S; Nagai T; Uemura O
Intern Med; 2017; 56(14):1849-1853. PubMed ID: 28717081
[TBL] [Abstract][Full Text] [Related]
39. Facioscapulohumeral muscular dystrophy.
Statland J; Tawil R
Neurol Clin; 2014 Aug; 32(3):721-8, ix. PubMed ID: 25037087
[TBL] [Abstract][Full Text] [Related]
40. Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry.
Nikolic A; Ricci G; Sera F; Bucci E; Govi M; Mele F; Rossi M; Ruggiero L; Vercelli L; Ravaglia S; Brisca G; Fiorillo C; Villa L; Maggi L; Cao M; D'Amico MC; Siciliano G; Antonini G; Santoro L; Mongini T; Moggio M; Morandi L; Pegoraro E; Angelini C; Di Muzio A; Rodolico C; Tomelleri G; Grazia D'Angelo M; Bruno C; Berardinelli A; Tupler R
BMJ Open; 2016 Jan; 6(1):e007798. PubMed ID: 26733561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
